Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Impact analysis of heart failure across European countries: an ESC-HFA position paper

Publikation: Bidrag til tidsskriftReviewpeer review

DOI

  1. Healthcare resource use of patients with transthyretin amyloid cardiomyopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. Three decades of heart transplantation: experience and long-term outcome

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel Syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  4. Alcohol Intake in Patients With Cardiomyopathy and Heart Failure: Consensus and Controversy

    Publikation: Bidrag til tidsskriftReviewpeer review

  • Giuseppe M C Rosano
  • Petar Seferovic
  • Gianluigi Savarese
  • Ilaria Spoletini
  • Yuri Lopatin
  • Fin Gustafsson
  • Antoni Bayes-Genis
  • Tiny Jaarsma
  • Magdy Abdelhamid
  • Arantxa Gonzalez Miqueo
  • Massimo Piepoli
  • Carlo G Tocchetti
  • Arsen D Ristić
  • Ewa Jankowska
  • Brenda Moura
  • Loreena Hill
  • Gerasimos Filippatos
  • Marco Metra
  • Davor Milicic
  • Thomas Thum
  • Ovidiu Chioncel
  • Tuvia Ben Gal
  • Lars H Lund
  • Dimitrios Farmakis
  • Wilfried Mullens
  • Stamatis Adamopoulos
  • Michael Bohm
  • Anna Norhammar
  • Andreas Bollmann
  • Amitava Banerjee
  • Aldo P Maggioni
  • Adriaan Voors
  • Alain Cohen Solal
  • Andrew J S Coats
Vis graf over relationer

Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs-in terms of quality of life-in European countries.

OriginalsprogEngelsk
TidsskriftESC Heart Failure
ISSN2055-5822
DOI
StatusE-pub ahead of print - 22 jul. 2022

Bibliografisk note

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

ID: 79741882